Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirley Ong

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
First Language|February 3, 2026
Children's endorsement of prosocial lies according to content and recipient knowledgeShirley Ong, Elizabeth S Nilsen
Case Reports in Neurological Medicine|April 10, 2014
Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case reportSajish Jacob, Harsh Gupta, Dejan Nikolic, et al.
Current Treatment Options in Oncology|October 6, 2021
Targeted Therapy for BRAF Mutant Brain TumorsAppaji Rayi, Iyad Alnahhas, Shirley Ong, et al.
American Journal of Clinical Oncology|September 5, 2020
False-positive 1p/19q Testing Results in Gliomas: Clinical and Research ConsequencesIyad Alnahhas, Appaji Rayi, Diana Thomas, et al.
Neuro-Oncology Advances|October 20, 2021
Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDH<i>wt</i> glioblastomaIyad Alnahhas, Appaji Rayi, Maria Del Pilar Guillermo Prieto Eibl, et al.
Neuro-Oncology Practice|March 5, 2021
The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort studyIyad Alnahhas, Appaji Rayi, Joshua D Palmer, et al.
Neuro-Oncology Advances|November 5, 2020
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Neuro-Oncology Advances|July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 26, 2015
Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literatureAl-Ola Abdallah, Aline Herlopian, Rahul Ravilla, et al.
Neurosurgery|February 21, 2025
Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control StudyMark A Damante, Joshua Vignolles-Jeong, Guilherme Finger, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
First Language|February 3, 2026
Children's endorsement of prosocial lies according to content and recipient knowledgeShirley Ong, Elizabeth S Nilsen
Case Reports in Neurological Medicine|April 10, 2014
Central pontine and extrapontine myelinolysis: the great masquerader-an autopsy case reportSajish Jacob, Harsh Gupta, Dejan Nikolic, et al.
Current Treatment Options in Oncology|October 6, 2021
Targeted Therapy for BRAF Mutant Brain TumorsAppaji Rayi, Iyad Alnahhas, Shirley Ong, et al.
American Journal of Clinical Oncology|September 5, 2020
False-positive 1p/19q Testing Results in Gliomas: Clinical and Research ConsequencesIyad Alnahhas, Appaji Rayi, Diana Thomas, et al.
Neuro-Oncology Advances|October 20, 2021
Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDH<i>wt</i> glioblastomaIyad Alnahhas, Appaji Rayi, Maria Del Pilar Guillermo Prieto Eibl, et al.
Neuro-Oncology Practice|March 5, 2021
The role of VEGF receptor inhibitors in preventing cerebral radiation necrosis: a retrospective cohort studyIyad Alnahhas, Appaji Rayi, Joshua D Palmer, et al.
Neuro-Oncology Advances|November 5, 2020
Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Neuro-Oncology Advances|July 14, 2021
Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysisIyad Alnahhas, Mouaz Alsawas, Appaji Rayi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 26, 2015
Ipilimumab-induced necrotic myelopathy in a patient with metastatic melanoma: A case report and review of literatureAl-Ola Abdallah, Aline Herlopian, Rahul Ravilla, et al.
Neurosurgery|February 21, 2025
Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control StudyMark A Damante, Joshua Vignolles-Jeong, Guilherme Finger, et al.
Pageof 2